Sleeping Pills Market Report 2026

Sleeping Pills Market Overview

• Sleeping Pills market size has reached to $85.87 billion in 2025 • Expected to grow to $126.55 billion in 2030 at a compound annual growth rate (CAGR) of 8% • Growth Driver: Increasing Prevalence Of Mental Illness Fueling The Growth Of The Market Due To Rising Chronic Stress And Its Impact On Sleep Quality • Market Trend: Advanced Formulations Aim To Improve Sleep Quality And Safety • North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Sleeping Pills Market?

Sleeping pills, also known as sedative-hypnotics, are medications used to help individuals fall asleep or stay asleep. They are commonly prescribed for short-term treatment of insomnia or other sleep disorders. Sleeping pills depress the central nervous system to induce drowsiness and promote restful sleep. The main types of sleeping pills are prescription sleeping pills and over-the-counter (OTC) sleeping pills. Sleeping pills refer to medications or supplements used to help people fall asleep, stay asleep, or improve the quality of sleep. These consists of different product types, such as benzodiazepines and non-benzodiazepines, and are used to treat various sleep disorders, including insomnia, sleep apnea, restless leg syndrome, narcolepsy, and sleepwalking. The demand for sleeping pills varies across different consumer demographics, such as age groups, gender, and health conditions, and these products are distributed through multiple channels, including retail pharmacies, online pharmacies, hospitals and clinics, and health and wellness stores.

What Is The Sleeping Pills Market Growth Forecast?

The sleeping pills market size is expected to see strong growth in the next few years. It will grow to $126.55 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to development of novel non-benzodiazepine drugs, rising adoption of melatonin and herbal supplements, increasing online pharmacy penetration, personalized sleep treatment programs, expanding geriatric and adult consumer base. Major trends in the forecast period include rising prevalence of sleep disorders globally, increased adoption of over-the-counter sleep aids, growing focus on personalized sleep therapy, expansion of online pharmacies and e-commerce channels, rising awareness about natural and herbal sleep supplements.

Global Sleeping Pills Market Segmentation

1) By Medication Type: Prescription Sleeping Pills, Over The Counter (OTC) Sleeping Pills 2) By Product Type: Benzodiazepines, Non Benzodiazepines 3) By Sleep Disorder: Insomnia, Sleep Disorder, Restless Leg Syndrome Narcolepsy, Sleepwalking 4) By Consumer Demographics: Age Groups, Gender, Health Conditions 5) By Distribution Channel: Retail Pharmacies, Online Pharmacies, Hospitals And Clinics, Health And Wellness Stores Subsegments: 1) By Prescription Sleeping Pills: Benzodiazepines, Non-Benzodiazepines, Antidepressants, Antihistamines, Melatonin Receptor Agonists, Orexin Receptor Antagonists 2) By Over The Counter (OTC): Diphenhydramine, Doxylamine, Melatonin Supplements, Valerian Root

What Is The Driver Of The Sleeping Pills Market?

The increasing prevalence of mental illness is expected to propel the growth of the sleeping pills market going forward. Mental illness refers to a wide range of mental health conditions that affect a person’s mood, thinking, behavior, and overall functioning. The prevalence of mental illness is increasing due to rising levels of chronic stress, as prolonged stress disrupts brain function and triggers or worsens mental health disorders. Sleeping pills aid in managing mental illness by improving sleep quality, which is essential for emotional and cognitive stability. They help reduce symptoms of anxiety and depression by promoting restful sleep and enhancing overall mental health and daily functioning. For instance, in 2025, according to the National Alliance on Mental Illness and NextStep Solutions Behavioral Health, US-based health agencies reported that serious mental illness (SMI) prevalence was about 5.44% in 2023 and remained close by 2024 at about 5.6% of adults, indicating stability in that severe category. Therefore, the increasing prevalence of mental illness is driving the growth of the sleeping pills industry.

Key Players In The Global Sleeping Pills Market

Major companies operating in the sleeping pills market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Cipla Limited, Aurobindo Pharma Ltd. , Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Mallinckrodt Pharmaceuticals plc, Idorsia Pharmaceuticals Ltd, Procter & Gamble Health Limited (P&G Health), Allegiant Health

Global Sleeping Pills Market Trends and Insights

Major companies operating in the sleeping pills market are focusing on developing advanced formulations, such as novel drug formulations, to enhance sleep quality, minimize dependency risks, and reduce side effects. Novel drug formulations refer to the development of new medication compositions designed to improve efficacy, enhance absorption, reduce side effects, and provide more targeted and patient-friendly treatment options. For instance, in October 2024, Neurovalens, a UK-based medical device company, launched Modius Sleep, a Food and Drug Administration (FDA)-cleared, physician-prescribed medical device designed to treat chronic insomnia in adults aged 22 and older. It uses low-level electrical vestibular nerve stimulation to target the hypothalamus and brainstem, areas that regulate sleep and circadian rhythms. The device is worn on the head for 30 minutes each evening, typically 1–2 hours before bedtime, with adjustable intensity for user comfort. Modius Sleep is easy to use, portable, and can be worn during activities such as reading or watching TV.

What Are Latest Mergers And Acquisitions In The Sleeping Pills Market?

In October 2023, Apnimed, a US-based pharmaceutical company, partnered with Shionogi & Co. Ltd. This joint venture aims to develop novel pharmacologic therapies for obstructive sleep apnea and other sleep disorders, focusing on innovative oral treatment options. Shionogi & Co. Ltd. is a Japan-based pharmaceutical company involved in developing innovative sleeping pills and oral treatments for sleep disorders.

Regional Insights

North America was the largest region in the sleeping pills market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Sleeping Pills Market?

The sleeping pills market consists of sales of over-the-counter antihistamines, melatonin supplements, and herbal or natural sleep remedies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Sleeping Pills Market Report 2026?

The sleeping pills market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sleeping pills industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.